Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23

Trial Status

Completed4
Terminated1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT06413537Phase 2Completed
Study of SPG601 in Adult Men With Fragile X Syndrome
Fragile X Syndrome
PrincipalinvestigatorStart date: 2024-07-05
NCT05163717Phase 2Terminated
INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD
Agitation in Adolescents and Young Adults With ASD
PrincipalinvestigatorStart date: 2022-06-23
NCT01911455Phase 1Completed
Study of Acamprosate in Fragile x Syndrome
Fragile X Syndrome
PrincipalinvestigatorStart date: 2013-08-27
NCT01894958Phase 2Completed
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Fragile X Syndrome
Principalinvestigator

Research Network

Collaboration Network

31 collaborators·65 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Children's Hospital Medical Center, Cincinnati

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alexander Kolevzon, MD

Icahn School of Medicine at Mount Sinai

Related
13 trials

Shared therapeutic areas:

Autism Spectrum DisorderFragile X Syndrome

Worked with same sponsors:

Neuren Pharmaceuticals Limited
Collaborated on 1 trial
Similarity Score24%

James McCracken, MD

University of California, Los Angeles

Related
8 trials

Shared therapeutic areas:

Autism Spectrum DisorderFragile X Syndrome
Similarity Score20%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Autism Spectrum DisorderFragile X Syndrome
Similarity Score20%

Forbes D Porter, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
15 trials

Shared therapeutic areas:

Autism Spectrum DisorderFragile X Syndrome
Similarity Score20%

Randi Hagerman, MD

UC Davis MIND Institute

Related
1 trials

Shared therapeutic areas:

Fragile X Syndrome

Worked with same sponsors:

Neuren Pharmaceuticals Limited
Collaborated on 1 trial
Similarity Score14%

Robert Findling, MD

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Related
2 trials

Shared therapeutic areas:

Fragile X Syndrome

Worked with same sponsors:

Neuren Pharmaceuticals Limited
Collaborated on 1 trial
Similarity Score14%

Stephen Shrewsbury, MD

Impel Pharmaceuticals

Related
1 trials

Shared therapeutic areas:

Agitation in Adolescents and Young Adults With ASD

Worked with same sponsors:

Impel Pharmaceuticals
Collaborated on 1 trial
Similarity Score14%

Nicole Tartaglia, MD

Children's Hospital Colorado

Related
1 trials

Shared therapeutic areas:

Fragile X Syndrome

Worked with same sponsors:

Neuren Pharmaceuticals Limited
Collaborated on 1 trial
Similarity Score14%

Bryan King, MD

Seattle Children's Hospital

Related
2 trials

Shared therapeutic areas:

Fragile X Syndrome

Worked with same sponsors:

Neuren Pharmaceuticals Limited
Collaborated on 1 trial
Similarity Score14%

Shivkumar Hatti, MD

Suburban Research Associates

Related
3 trials

Shared therapeutic areas:

Fragile X Syndrome

Worked with same sponsors:

Neuren Pharmaceuticals Limited
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06413537Phase 2PrincipalInvestigator

Study of SPG601 in Adult Men With Fragile X Syndrome

Fragile X Syndrome
Completed
NCT05163717Phase 2PrincipalInvestigator

INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD

Agitation in Adolescents and Young Adults With ASD
Terminated
NCT04644003Phase 1PrincipalInvestigator

Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD)

Autism Spectrum Disorder
Completed
NCT01911455Phase 1PrincipalInvestigator

Study of Acamprosate in Fragile x Syndrome

Fragile X Syndrome
Completed
NCT01894958Phase 2PrincipalInvestigator

A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

Fragile X Syndrome
Completed

All 5 trials loaded